Johnson & Johnson (JNJ) Tops Q1 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
Go back to Johnson & Johnson (JNJ) Tops Q1 EPS by 6c
April 17, 2019 8:43 AM EDT
Stifel analyst Rick Wise raised the price target on Johnson & Johnson (NYSE: JNJ) to $140.00 (from $135.00) while maintaining a Hold rating. 1Q19 sales and EPS outperformed expectations and management raised operational sales growth and underlying EPS outlooks. The results were buoyed by better-thanexpected Pharmaceutical and... More
April 17, 2019 7:42 AM EDT
Raymond James analyst Jayson Bedford raised the price target on Johnson & Johnson (NYSE: JNJ) to $147.00 (from $145.00) while maintaining a Outperform rating.
growth was still much better than expected, which gives us more confidence in our estimates...
More
April 17, 2019 6:56 AM EDT
BMO Capital analyst Joanne Wuensch raised the price target on Johnson & Johnson (NYSE: JNJ) to $157.00 (from $154.00) while maintaining a Outperform rating.
Staying On Course in Its Transition Year
tightening EPS to $8.53-$8.63 from $8.50-$8.65
...
More
April 17, 2019 6:37 AM EDT
RBC Capital analyst Brandon Henry raised the price target on Johnson & Johnson (NYSE: JNJ) to $150.00 (from $144.00) while maintaining a Outperform rating.
Strong start to 2019; revised guidance appears conservative...
More
